J Geriatr Oncol
Antibodies, MonoclonalAntineoplastic Agents, ImmunologicalGeriatric Assessment
Dr. Joseph Thomas Kannarkatt, MD
NPI1124311956PAC ID2466728258
- Medicare services, 2024
- 99,672
- Medicare patients, 2024
- 875
- Part D claims, 2024
- 1,156
- Publications
- 3
- Clinical trials
- 4
- Practice address
- 25 Monument Road, Suite 270, York, PA 17403
- Practice phone
- Call (717) 741-8250
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Apple Hill Surgical Center
Surgery Center - Medicare-Certified · York, Pennsylvania
Find Dr. Kannarkatt's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Joseph Thomas Kannarkatt is a hematologist and oncologist in York, Pennsylvania
Dr. Kannarkatt practices at Apple Hill Surgical Center in York, Pennsylvania.
Dr. Kannarkatt's NPI, 1124311956, was assigned on May 26, 2011. Dr. Kannarkatt graduated from Jefferson Medical College of Thomas Jefferson University in 2011. Dr. Kannarkatt holds Pennsylvania license MD462352.
NPI and contact details
- NPI
- 1124311956NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2466728258
- NPI enumeration date
- May 26, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (717) 741-8250
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Joseph Thomas Kannarkatt practices at Apple Hill Surgical Center in York, Pennsylvania
Dr. Kannarkatt's primary practice is Apple Hill Surgical Center, at 25 Monument Road, Suite 270, York, PA 17403. The practice phone is (717) 741-8250.
- Apple Hill Surgical Center25 Monument Road, Suite 270, York, PA 17403Phone(717) 741-8250
Source: Dmand AI Affiliation Data
Dr. Joseph Thomas Kannarkatt is affiliated with 4 sites of care and 1 medical group
Dr. Kannarkatt's primary practice is Apple Hill Surgical Center in York, Pennsylvania. Dr. Kannarkatt is also affiliated with WellSpan York Hospital. The medical group on file is Cancer Care Associates of York. Dmand AI also links Dr. Kannarkatt to 1 more hospital and 1 group practice or clinic, each named with a free account.
Apple Hill Surgical CenterPrimary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Joseph Thomas Kannarkatt's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kannarkatt practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Apple Hill Surgical Center | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kannarkatt practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Joseph Thomas Kannarkatt is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Kannarkatt's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kannarkatt is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Kannarkatt
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Joseph Thomas Kannarkatt billed Medicare for 99,672 services in 2024
CMS data shows 99,672 Medicare services from Dr. Kannarkatt across 68 procedure codes in 2024, for 875 Medicare patients. Medicare paid $1,827,181 for them.
Medicare services, 202499,672
Medicare patients875
Paid by Medicare$1.8M
Procedure codes68
Dr. Kannarkatt's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 104,3142024: 90,60613%
- Lab and pathology
- 2023: 3,0452024: 3,1333%
- Tests and treatments
- 2023: 2,0402024: 1,72915%
- Office and hospital visits
- 2023: 1,4642024: 1,4932%
- Surgery
- 2023: 1,3632024: 1,4829%
- Other services
- 2023: 1,9052024: 1,22935%
Where Dr. Kannarkatt's Medicare services took place, 2024
- In an office99,529100%
- In a facility1430%
Dr. Kannarkatt compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Kannarkatt
- Pennsylvania median
- Medicare services
- 99,672vs 654152.4 times
- Medicare patients
- 875vs 2273.9 times
- Part D claims
- 904vs 3932.3 times
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Kannarkatt's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kannarkatt?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kannarkatt and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Joseph Thomas Kannarkatt treated 875 Medicare patients in 2024, average age 75
CMS counts 875 Medicare patients who saw Dr. Kannarkatt in 2024. The largest group is 65 to 74, with 360 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kannarkatt's median patient age at 74, with 51% women.
Medicare patients, 2024875
Average age75
Average risk score2.48
Also on Medicaid8%
Dr. Kannarkatt's Medicare patients by age, 2024
Dr. Kannarkatt's Medicare patients by sex, 2024
- Women47454%
- Men40146%
Chronic conditions among Dr. Kannarkatt's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis49%
- Cancer49%
- Chronic kidney disease39%
- Ischemic heart disease38%
- Diabetes35%
- Anxiety32%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kannarkatt's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women51%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Joseph Thomas Kannarkatt wrote 1,156 Medicare Part D claims in 2024
In 2024, Dr. Kannarkatt wrote 1,156 Medicare Part D claims for 244 patients. 86% of them were for generic drugs. CMS names the drug for 904 of them, across 22 drugs with 11 or more claims each, at $277,435 in total drug cost. In 2023, CMS named 812 claims across 20 drugs.
Part D claims, 20241,156
Drugs named by CMS22
Total drug cost$277,435
Part D patients244
Dr. Kannarkatt's Part D claims by kind of drug, 2024
- Generic990 claims86%
- Brand-name166 claims14%
Dr. Kannarkatt's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kannarkatt's Part D claims, 2024
- Opioids2%18 of 1,156 claims
- Antibiotics3%31 of 1,156 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 8122024: 90411%
Drugs named by CMS: 22 in 2024, 20 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Joseph Thomas Kannarkatt scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kannarkatt for performance year 2024, reported individually. Dr. Kannarkatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kannarkatt as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Kannarkatt's MIPS scores, performance year 2024
- 100of 100Final score
- 100of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Kannarkatt by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Joseph Thomas Kannarkatt has 3 publications on record
Dmand AI links 3 papers to Dr. Kannarkatt, published from 2016 to 2018. Dr. Kannarkatt's most frequent co-authors are Omar Alkharabsheh, MD, Anas Al-Janadi, MD and Lilit Karapetyan, MD.
Papers3
Years published2016 to 2018
Dr. Kannarkatt's most frequent co-authors
- Omar Alkharabsheh, MD2 shared papers
- Anas Al-Janadi, MD1 shared paper
- Lilit Karapetyan, MD1 shared paper
Recent publications by Dr. Kannarkatt
See who Dr. Kannarkatt researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kannarkatt works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Joseph Thomas Kannarkatt has worked on 4 clinical trials
Dmand AI links Dr. Kannarkatt to 4 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Thyroid Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.
Conditions in Dr. Kannarkatt's trials
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Thyroid Neoplasms
- Carcinoma, Bronchogenic
- Thoracic Neoplasms
Investigators on the most trials with Dr. Kannarkatt
- Michael A. Finan, MD3 shared trials
- John J. Inzerillo, MD3 shared trials
- Tyler Yu-Tai Kang, MD3 shared trials
Recent clinical trials with Dr. Kannarkatt
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 2
Lung NeoplasmsThoracic NeoplasmsNivolumabCabozantinib S-malateDocetaxel
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy (opens in a new tab)
Active, not recruitingPhase 2
DocetaxelNab-paclitaxelPaclitaxel
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (opens in a new tab)
Active, not recruitingPhase 2
Thyroid NeoplasmsThyroid DiseasesAdavosertibAfatinibAfatinib Dimaleate
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) (opens in a new tab)
Active, not recruiting
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicCarboplatinCisplatinCrizotinib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Joseph Thomas Kannarkatt received $34,990 in industry payments from 2016 to 2025
CMS Open Payments shows 184 general payments to Dr. Kannarkatt from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. OnMark, Inc. paid the most, $19,662.
General payments to Dr. Kannarkatt by program year, 2016 to 2025
General payments to Dr. Kannarkatt by kind, 2016 to 2025
$35Kin total
- Consulting fees$22,14863%
- Honoraria$5,25015%
- Food and beverage$3,44010%
- Travel and lodging$2,1986%
- Other$1,9346%
Companies that paid Dr. Kannarkatt the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Joseph Thomas Kannarkatt graduated from Jefferson Medical College of Thomas Jefferson University
Dr. Kannarkatt graduated from Jefferson Medical College of Thomas Jefferson University in 2011.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Joseph Thomas Kannarkatt's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Joseph Thomas Kannarkatt
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Joseph Thomas Kannarkatt's NPI number?
Dr. Joseph Thomas Kannarkatt's NPI number is 1124311956. It was assigned on May 26, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Joseph Thomas Kannarkatt?
Dr. Joseph Thomas Kannarkatt is a hematologist and oncologist in York, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Joseph Thomas Kannarkatt practice?
Dr. Kannarkatt practices at 25 Monument Road, Suite 270, York, PA 17403. Dr. Kannarkatt's primary practice is Apple Hill Surgical Center in York, Pennsylvania. Dmand AI also links Dr. Kannarkatt to 1 hospital and 1 group practice or clinic.
What is Dr. Joseph Thomas Kannarkatt's office phone number?
The practice phone on file for Dr. Kannarkatt is (717) 741-8250.
What is Dr. Joseph Thomas Kannarkatt's medical license number?
Dr. Kannarkatt holds Pennsylvania license MD462352.
Which hospitals is Dr. Joseph Thomas Kannarkatt affiliated with?
Dr. Kannarkatt is affiliated with WellSpan York Hospital. Dmand AI links Dr. Kannarkatt to 1 more hospital.
What medical group is Dr. Joseph Thomas Kannarkatt part of?
Dr. Kannarkatt is linked to Cancer Care Associates of York.
Does Dr. Joseph Thomas Kannarkatt accept Medicare?
Yes. CMS data shows Dr. Kannarkatt billed Medicare for 99,672 services in 2024, and Dr. Kannarkatt accepts Medicare assignment.
Does Dr. Joseph Thomas Kannarkatt offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kannarkatt as offering telehealth services.
What is Dr. Joseph Thomas Kannarkatt's MIPS score?
Dr. Kannarkatt's MIPS final score for performance year 2024 is 100 out of 100, reported individually.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Joseph Thomas Kannarkatt see?
CMS counts 875 Medicare patients who saw Dr. Kannarkatt in 2024, with an average age of 75.
What services does Dr. Joseph Thomas Kannarkatt bill to Medicare?
In 2024, Dr. Kannarkatt's most billed Medicare services were injected or infused drug (J0881), injected or infused drug (J9299) and injected or infused drug (J9271).
Where did Dr. Joseph Thomas Kannarkatt go to medical school?
Dr. Kannarkatt graduated from Jefferson Medical College of Thomas Jefferson University in 2011.
What drugs does Dr. Joseph Thomas Kannarkatt prescribe most?
In 2024 Medicare Part D data, Dr. Kannarkatt's most prescribed drugs by claims were Dexamethasone, Anastrozole and Prochlorperazine Maleate.
Has Dr. Joseph Thomas Kannarkatt received payments from drug or device companies?
CMS Open Payments shows $34,990 in general payments to Dr. Kannarkatt from 41 companies from 2016 to 2025. The largest total came from OnMark, Inc.
How long has Dr. Joseph Thomas Kannarkatt been practicing?
Dr. Kannarkatt graduated from medical school in 2011, 15 years ago.
Does Dr. Joseph Thomas Kannarkatt do research?
Dmand AI links 3 publications to Dr. Kannarkatt, published from 2016 to 2018. Dr. Kannarkatt has worked on 4 clinical trials.
Who does Dr. Joseph Thomas Kannarkatt publish with?
Dr. Kannarkatt's most frequent co-authors are Omar Alkharabsheh, MD (2 shared papers), Anas Al-Janadi, MD (1 shared paper) and Lilit Karapetyan, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card